Cargando…
Imaging as an End Point in Ischemia Trials
Imaging of cardiac function and anatomy has advanced at an exponential rate over the past two decades. Our ability to quantitatively assess the degree of myocardial ischemia and accurately define the vascular anatomy using noninvasive techniques is greater than ever before. Current advances is cardi...
Autores principales: | Howarth, Andrew G., Friedrich, Matthias G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047679/ https://www.ncbi.nlm.nih.gov/pubmed/21475396 http://dx.doi.org/10.1007/s12410-011-9068-6 |
Ejemplares similares
-
Surrogate end points and their role in clinical trial
por: Jaykaran,
Publicado: (2009) -
Clinical Trial End Points in Severe COVID-19
por: Desai, Aakash, et al.
Publicado: (2020) -
End-point definition and trial design to advance tuberculosis vaccine development
por: Garcia-Basteiro, Alberto L., et al.
Publicado: (2022) -
Systematic adjudication of myocardial infarction end-points in an international clinical trial
por: Mahaffey, Kenneth W, et al.
Publicado: (2001) -
Risk characterization framework for noncancer end points.
por: Pierson, T K, et al.
Publicado: (1991)